{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Analgesics",
      "Antibiotics",
      "Antihypertensives",
      "Athletes",
      "Insulin",
      "Medication use",
      "Sports medicine",
      "Therapeutic use exemptions"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32014136",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "10"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "12",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "10",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.pop.2019.10.003",
      "S0095-4543(19)30083-1"
    ],
    "Journal": {
      "ISSN": "1558-299X",
      "JournalIssue": {
        "Volume": "47",
        "Issue": "1",
        "PubDate": {
          "Year": "2020",
          "Month": "Mar"
        }
      },
      "Title": "Primary care",
      "ISOAbbreviation": "Prim Care"
    },
    "ArticleTitle": "Common Prescription Medications Used in Athletes.",
    "Pagination": {
      "StartPage": "49",
      "EndPage": "64",
      "MedlinePgn": "49-64"
    },
    "Abstract": {
      "AbstractText": [
        "Athletes of various skill levels commonly use many different types of medications, often at rates higher than the general population. Common medication classes used in athletes include analgesics such as nonsteroidal anti-inflammatory drugs and acetaminophen, inhalers for asthma and exercise-induced bronchoconstriction, antihypertensives, antibiotics, and insulin. Prescribers must be aware of the unique considerations for each of these medications when using them in patients participating in physical activity. The safety, efficacy, impact on athletic performance, and regulatory restrictions of the most common medications used in athletes are discussed in this article."
      ],
      "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Trident/MUSC Family Medicine Residency Program, Department of Family Medicine, Medical University of South Carolina, 9228 Medical Plaza Drive, Charleston, SC 29406, USA."
          }
        ],
        "LastName": "Ferry",
        "ForeName": "Benjamin",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Family Medicine, Medical University of South Carolina, College of Medicine, 9228 Medical Plaza Drive, Charleston, SC 29406, USA."
          }
        ],
        "LastName": "DeCastro",
        "ForeName": "Alexei",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Family Medicine, College of Medicine, College of Pharmacy, Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina, 280 Calhoun Street MSC 140, Charleston, SC 29425, USA. Electronic address: braggsc@musc.edu."
          }
        ],
        "LastName": "Bragg",
        "ForeName": "Scott",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Prim Care",
    "NlmUniqueID": "0430463",
    "ISSNLinking": "0095-4543"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenal Cortex Hormones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenergic beta-Agonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Analgesics"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antihypertensive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Insulin"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prescription Drugs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenal Cortex Hormones"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenergic beta-Agonists"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Analgesics"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antihypertensive Agents"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Asthma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Athletes"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Diabetes Mellitus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Hypertension"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Insulin"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Prescription Drugs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sports Medicine"
    }
  ],
  "CoiStatement": "Disclosure The authors of this article have no financial relationships or affiliations to disclose."
}